News

Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on ...
The results showed country-specific challenges, such as elevated OTA in southern Europe and FUM across Latin America and ...
A mouse study showed a link between an infection with herpes simplex virus type 1 (HSV-1), the cause of cold sores, and MS.
An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...
Antonella Favit-Van Pelt, MD, PhD, discusses the use of neuromodulation and neuroplasticity for addressing gait deficits in patients with multiple sclerosis.
Multiple sclerosis, the prototype of demyelinating disease in man, is a relapsing-remitting or progressively disabling disease of unknown cause. The first pathological descriptions of the disease ...
In relapsing-remitting multiple sclerosis, activation of the peripheral immune system can lead to focal inflammation within the CNS. Over the past three decades, therapeutic development has been ...
In part 2, Hans Lee, MD, shares practical tips for using linvoseltamab in heavily pretreated multiple myeloma and outlines trials that may expand its future role.
The newly approved linvoseltamab (Lynozyfic; Regeneron) has a manageable safety profile, along with a patient-friendly dosing ...
Multiple myeloma (MM) remains a complex and heterogeneous hematologic malignancy with evolving therapeutic challenges. In recent years, immunotherapy has ...